Localisation and activity of cathepsins K and B in equine osteoclasts

Research in Veterinary Science

Volumn 72, Issue 2, 2002, Pages 95-103

  Gray, A W ^a   Davies, M E ^a   Jeffcott, L B ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN B; CATHEPSIN K; CYSTEINE PROTEINASE INHIBITOR; N [N (3 CARBOXYOXIRANE 2 CARBONYL)LEUCYL]AGMATINE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; AUTOPSY; BLOOD VESSEL; BONE DEVELOPMENT; BONE MARROW CULTURE; CARTILAGE; CARTILAGE CELL; CELL LEVEL; CHONDROLYSIS; CONTROLLED STUDY; DEVELOPMENTAL DISORDER; ENCHONDRAL OSSIFICATION; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME LOCALIZATION; ENZYME SUBSTRATE; FEMUR; FETUS; HORSE; IMMUNOLOCALIZATION; IN VITRO STUDY; LONG BONE; NONHUMAN; ORTHOPEDICS; OSTEOCLAST; OSTEOLYSIS; PATHOGENESIS; PROTEIN EXPRESSION;

EQUIDAE; EQUUS CABALLUS;

EID: 0036088545     PISSN: 00345288     EISSN: None     Source Type: Journal    
DOI: 10.1053/rvsc.2001.0522     Document Type: Article

References (56)

1. Osteogenesis
2. Supportive tissues-bone
3. Osteoclastic bone resorption by a polarised vacuolar proton pump
4. Proteinase expression during differentiation of human osteoclasts in vitro
5. Proteolytic activity of human osteoclast cathepsin K
6. Human cathepsin O2, a matrix-degrading cysteine protease expressed in osteoclasts
7. CA074 methyl ester: A proinhibitor for intracellular cathepsin B
8. Tartrate-resistant acid phosphatase in bone and cartilage following decalcification and cold-embedding in plastic
9. Intercellular adhesion molecule-1 (ICAM-1) and MHC class II on chondrocytes in arthritic joints from pigs experimentally infected with Erysipelothrix rhusiopathiae
10. In vivo and in vitro evidence for the involvement of cysteine proteinases in bone resorption
11. Collagenolytic cysteine proteinases of bone tissue
12. Proteinases in bone resorption: Obvious and less obvious roles
13. Cathepsin K mRNA detection is restricted to osteoclasts during fetal mouse development
14. Human osteoclast cathepsin K is processed intracellulary prior to attachment and bone resorption
15. Cathepsin K, but not cathepsins B, L, or S, is abundantly expressed in human osteoclasts
16. Effects of the proteinase inhibitors leupeptin and E-64 on osteoclastic bone resorption
17. Cysteine proteinases and matrix metalloproteinases play distinct roles in the subosteoclastic resorption zone
18. Functional heterogeneity of osteoclasts: Matrix metalloproteinases participate in osteoclastic resorption of calvarial bone but not in resorption of long bone
19. The collagenolytic activity of cathepsin K is unique among mammalian proteinases
20. Localisation of cathepsins B, D, and L in the rat osteoclast by immuno-light and electron microscopy
21. Cathepsin K knockout mice develop osteopetrosis due to a deficit in matrix degradation but not demineralisation
22. Equine osteoclast-like cells generated in vitro demonstrate similar characteristics to directly isolated mature osteoclasts
23. Generation and activity of equine osteoclasts in vitro: Effects of the bisphosphonate pamidronate (APD)
24. Immunolocalisation of cathepsin B in equine dyschondroplastic articular cartilage
25. Inhibition of bone resorption by selective inactivators of cysteine proteinases
26. Cysteine proteinase cathepsin K mRNA is expressed in synovium of patients with rheumatoid arthritis and is detected at sites of synovial bone destruction
27. Molecular cloning of human cDNA for cathepsin K: Novel cysteine proteinase predominantly expressed in bone
28. Cathepsin K antisense oligodeoxynucleotide inhibits osteoclastic bone resorption
29. Osteochondrosis - An international problem for the horse industry
30. Human cathepsin K cleaves native type I and II collagens at the N-terminal end of the triple helix
31. Participation of cathepsin L on bone resorption
32. Fluorescence microscopic demonstration of cathepsin K activity as the major lysosomal cysteine proteinase in osteoclasts
33. Structure-based development of pyridoxal propionate derivatives as specific inhibitors of cathepsin K in vitro and in vivo
34. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation
35. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
36. Osteoclasts express the B2 isoform of vacuolar H+ -ATPase intracellularly and on their plasma membranes
37. Osteoclast formation and resorption
38. Characterisation of mouse cathepsin K gene, the gene promoter, and the gene expression
39. Localisation of cathepsin K in human osteoclasts by in situ hybridisation and immunohistochemistry
40. Bioactivity of parathyroid hormone-like peptide: Agonist and antagonist activities of amino terminal fragments as assessed by the cytochemical bioassay and in situ hybridisation
41. Bone acid phosphatase: Tartrate-resistant acid phosphatase as a marker of osteoclast function
42. Human osteoclastomas contain multiple forms of cathepsin B
43. A combination of osteoclast differentiation factor and macrophage-colony stimulating factor is sufficient for both human and mouse osteoclast formation in vitro
44. Mouse cathepsin K: cDNA cloning and predominant expression of the gene in osteoclasts, and in some hypertrophying chondrocytes during mouse development
45. Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin K-deficient mice
46. Cytochemical localisation of cathepsin B, dipeptidyl peptidase I, and dipeptidyl peptidase II in rat bone
47. Cysteine-proteinase localisation in osteoclasts: An immunocytochemical study
48. Zeolite A inhibits osteoclast-mediated bone resorption in vitro
49. Cathepsin expression during skeletal development
50. Molecular cloning of a possible cysteine proteinase predominantly expressed in osteoclasts
51. Design of potent and selective human cathepsin K inhibitors that span the active site
52. +-ATPase type in the ruffled borders of osteoclasts
53. Localisation of cathepsin B activity in fibroblasts and chondrocytes by continuous monitoring of the formation of a final fluorescent reaction product using 5-nitrosalicylaldehyde
54. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL
55. Study of immunoelectron microscopic localisation of cathepsin K in osteoclasts and other bone cells in the mouse femur
56. Localisation of rat cathepsin K in osteoclasts and resorption pits: Inhibition of bone resorption and cathepsin K activity by peptidyl vinyl sulfones